Sofinnova Crossover I → Abivax S.A. AAVXF

Stake: — Shares: 5,499,478 Class: Ordinary Shares, par value EUR0.01 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 999.99

139,370 shares short · +3.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $392.31M

Point72 Asset Mgmt

Post-Filing Returns · since 2026-05-07 on AAVXF

+1 day

0.0%

+5 days

0.0%

+30 days

-12.5%

+60 days

-30.8%

+90 days

—

+180 days

—

Anchor price 115.65 on closest trading day on/after 2026-05-07. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Abivax S.A.

Filed	Form	Filer	Stake	Shares
2026-07-06	SCHEDULE 13D/A	Sofinnova Crossover I	4.30%	3,535,843	view →
2025-07-31	SCHEDULE	Sofinnova Crossover I	11.40%	9,599,478	view →
2025-02-14	SCHEDULE	Sofinnova Crossover I	11.00%	7,794,478	view →

Other Filings by Sofinnova Crossover I

Filed	Form	Issuer	Stake	Shares
2026-07-06	SCHEDULE 13D/A	Abivax S.A. AAVXF	4.30%	3,535,843	view →
2025-07-31	SCHEDULE	Abivax S.A. AAVXF	11.40%	9,599,478	view →
2025-02-14	SCHEDULE	Abivax S.A. AAVXF	11.00%	7,794,478	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →